UGOLINI, CLARA
 Distribuzione geografica
Continente #
NA - Nord America 9.876
EU - Europa 5.590
AS - Asia 4.921
SA - Sud America 806
AF - Africa 312
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.512
Nazione #
US - Stati Uniti d'America 9.621
IT - Italia 2.245
SG - Singapore 1.686
CN - Cina 1.365
SE - Svezia 992
HK - Hong Kong 921
DE - Germania 766
BR - Brasile 669
GB - Regno Unito 394
BG - Bulgaria 279
VN - Vietnam 238
TR - Turchia 197
AT - Austria 182
CA - Canada 174
RU - Federazione Russa 161
CI - Costa d'Avorio 148
FI - Finlandia 146
IN - India 125
FR - Francia 106
JP - Giappone 74
NL - Olanda 74
SN - Senegal 66
BD - Bangladesh 58
UA - Ucraina 53
KR - Corea 49
AR - Argentina 44
PL - Polonia 42
MX - Messico 40
IQ - Iraq 29
ZA - Sudafrica 28
BE - Belgio 26
CH - Svizzera 25
ID - Indonesia 25
SA - Arabia Saudita 24
ES - Italia 21
EC - Ecuador 19
NG - Nigeria 19
VE - Venezuela 19
CO - Colombia 16
IR - Iran 16
JO - Giordania 14
LT - Lituania 14
PK - Pakistan 13
MA - Marocco 12
UZ - Uzbekistan 12
CL - Cile 10
KE - Kenya 10
NP - Nepal 10
UY - Uruguay 10
CZ - Repubblica Ceca 9
EE - Estonia 8
PT - Portogallo 8
PY - Paraguay 8
TN - Tunisia 8
TW - Taiwan 8
AZ - Azerbaigian 7
IL - Israele 7
PE - Perù 7
GR - Grecia 6
IE - Irlanda 6
RO - Romania 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
MY - Malesia 5
PA - Panama 5
PH - Filippine 5
PS - Palestinian Territory 5
AU - Australia 4
BB - Barbados 4
DO - Repubblica Dominicana 4
LB - Libano 4
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
GA - Gabon 3
HU - Ungheria 3
JM - Giamaica 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GD - Grenada 2
GH - Ghana 2
GT - Guatemala 2
GY - Guiana 2
MN - Mongolia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
Totale 21.485
Città #
Ashburn 1.231
Dallas 1.056
Hong Kong 907
Singapore 875
Fairfield 789
Santa Clara 675
Chandler 630
Woodbridge 601
Houston 449
Ann Arbor 441
Shanghai 354
Milan 330
Seattle 328
Beijing 301
Sofia 278
Wilmington 271
New York 258
Cambridge 253
Los Angeles 201
Boardman 179
Vienna 161
Princeton 151
Abidjan 148
London 146
Munich 141
Lawrence 132
Pisa 124
Ottawa 120
Florence 119
Medford 109
Rome 101
Izmir 98
Serra 97
Frankfurt am Main 74
Nanjing 72
Des Moines 67
Dakar 66
Hefei 64
Istanbul 64
Redondo Beach 59
Tokyo 58
Buffalo 57
Naples 56
São Paulo 56
Bremen 55
Ho Chi Minh City 55
San Diego 52
Jacksonville 49
Turku 48
Cascina 47
Dearborn 43
Seoul 43
Columbus 38
Bologna 34
The Dalles 33
Boulder 32
Ogden 31
Nanchang 29
Dong Ket 28
Hanoi 27
Council Bluffs 26
Fuzhou 26
Warsaw 25
Brussels 24
Genoa 24
Vicopisano 23
Brooklyn 22
Chicago 22
Lancaster 22
Phoenix 21
Changsha 20
Düsseldorf 20
Orem 20
Rio de Janeiro 20
Stockholm 20
Bern 19
Helsinki 19
Lagos 19
Poplar 19
Turin 19
Chennai 18
Nuremberg 18
Redmond 18
Lucca 17
Pune 17
Quanzhou 17
Denver 16
Hangzhou 16
Norwalk 16
Redwood City 16
Ankara 15
Atlanta 15
Belo Horizonte 15
Brasília 15
Montreal 15
San Francisco 15
San Jose 15
Washington 15
Baghdad 14
Johannesburg 14
Totale 14.138
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.091
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 323
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 236
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 224
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 219
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 213
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 207
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 206
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 206
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 200
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 189
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 188
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 187
HISTIDINE-RICH GLYCOPROTEIN AND HUMAN SKELETAL MUSCLE: POSSIBLE INVOLVEMENT IN MUSCLE CONTRACTION 185
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 176
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 174
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 172
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 170
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer 170
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 169
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 168
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 167
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 165
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 165
Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study. 164
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 163
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 163
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 162
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 162
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 162
null 160
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 160
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 159
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 159
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 158
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 158
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications 157
Role of YAP-1 in Thyroid Tumor Progression and Outcome 157
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 154
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 153
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 153
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 152
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 152
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 151
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 151
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 151
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 150
miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas 149
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 149
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation 149
Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role 148
Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer 147
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 147
Chronic lithium re-sizes motor neurons and induces neuronogenesis in the spinal cord of a mouse model of amyotrophic lateral sclerosis 146
Identification of targets of twist1 transcription factor in thyroid cancer cells 146
A microRNA signature for the differential diagnosis of salivary gland tumors 146
Synchronous Squamous Cell Carcinoma and Papillary Thyroid Carcinoma Arising from the Thyroglossal Duct Remnant: case report and a review of the literature. 146
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 146
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 146
Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management 146
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 146
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 143
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 143
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 143
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 142
EVIDENCE OF A LOW PREVALENCE OF RAS MUTATIONS IN A LARGE MEDULLARY THYROID CANCER SERIES 141
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 141
Effects of proton pump inhibitors on healing of gastric ulcerations induced by a continued non steroidal anti-inflammatory drug (NSAID) treatment 138
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 138
COVID-19 autopsy cases: detection of virus in endocrine tissues 138
Differences in miRNA expression profiles between wild-type and mutated NIFTPs 137
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 136
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like 136
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. 134
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior 134
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 134
Correlation Between The Presence Of Macrophages And Braf V600e Mutation In Different Variants Of Well Differentiated Papillary Thyroid Cancer 134
A dual mechanism of activation of the sonic hedgehog pathway in anaplastic thyroid cancer: Crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma 134
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 133
Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia 133
Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules 132
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 132
Human α-L-fucosidase-1 attenuates the invasive properties of thyroid cancer 132
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study 131
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 131
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience 130
Mast cells have a protumorigenic role in human thyroid cancer 130
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. 130
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 130
Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene 129
L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients 127
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma 127
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features 127
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens 126
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 124
Functional Characterization of the Novel T599I-VKSRdel BRAF Mutation in a Follicular Variant Papillary Thyroid Carcinoma 123
A retrospective analysis of her-2 hyperexpression in gastric and gastroesophageal junction (gej). 117
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study 117
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 113
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications. 111
Totale 16.369
Categoria #
all - tutte 65.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021726 0 0 0 0 0 60 192 68 132 75 67 132
2021/20221.607 47 38 56 109 302 236 62 74 76 72 122 413
2022/20232.640 331 408 187 195 250 289 58 190 441 46 193 52
2023/20241.999 185 168 187 202 246 285 158 86 78 89 125 190
2024/20255.758 134 228 97 331 556 556 466 278 606 681 575 1.250
2025/20264.250 472 882 959 627 738 572 0 0 0 0 0 0
Totale 21.890